A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)
Clinical trial NCT01590797 · COMPLETED
Trial details
- NCT number
- NCT01590797
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-10
- Primary completion
- 2014-06-11
- Enrollment
- 467
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.